Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReSymmetry was an Israeli health technology and medical device company developing AI-enabled robotic seating systems for wheelchair and rehabilitation users. Its core product concept used embedded sensors, data analytics, and automated movement control to continuously assess seated posture and proactively adjust seating position to reduce the harms of prolonged motionless sitting. The company positioned its technology for motorized wheelchairs and rehabilitative seating, with broader applications mentioned for office, automotive, and aircraft seating. ReSymmetry partnered with Karma Medical Devices in 2020 to develop and manufacture a smart seating system, but multiple company databases now list ReSymmetry as closed or out of business. The company appears to have remained a private venture-stage medtech startup rather than a drug-developing biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReSymmetry.